This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Gajendran Sundarababu: Innovator in Therapeutic Heterocycles
Introduction
Gajendran Sundarababu is a notable inventor based in West Chester, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic heterocycles. His innovative work has led to the granting of a patent, showcasing his expertise and dedication to advancing medical science.
Latest Patents
Gajendran holds a patent for therapeutic heterocycles, which are crucial in the development of new medications. This patent represents his commitment to creating effective treatments that can improve patient outcomes. He has been recognized for his innovative approach in this area, with 1 patent to his name.
Career Highlights
Gajendran is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca allows him to work on cutting-edge research and development projects that aim to address unmet medical needs. His contributions to the company have been instrumental in advancing their therapeutic offerings.
Collaborations
Gajendran has collaborated with esteemed colleagues, including William Jackson Frazee and Bipinchandra Chaudhari. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas. Together, they work towards developing new solutions in the pharmaceutical industry.
Conclusion
Gajendran Sundarababu is a dedicated inventor whose work in therapeutic heterocycles has made a significant impact in the field of pharmaceuticals. His contributions at AstraZeneca AB and his collaborations with fellow researchers highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
